Promyelocytic leukemia nuclear bodies (PM NBs), often referred to as membraneless organelles, are dynamic macromolecular protein complexes composed of a PML protein core and other transient or permanent components. PML NBs have been shown to play a role in a wide variety of cellular processes. This review describes in detail the diverse and complex interactions between small and medium size DNA viruses and PML NBs that have been described to date. The PML NB components that interact with small and medium size DNA viruses include PML protein isoforms, ATRX/Daxx, Sp100, Sp110, HP1, and p53, among others. Interaction between viruses and components of these NBs can result in different outcomes, such as influencing viral genome expression and/or replication or impacting IFN-mediated or apoptotic cell responses to viral infection. We discuss how PML NB components abrogate the ability of adenoviruses or Hepatitis B virus to transcribe and/or replicate their genomes and how papillomaviruses use PML NBs and their components to promote their propagation. Interactions between polyomaviruses and PML NBs that are poorly understood but nevertheless suggest that the NBs can serve as scaffolds for viral replication or assembly are also presented. Furthermore, complex interactions between the HBx protein of hepadnaviruses and several PML NBs-associated proteins are also described. Finally, current but scarce information regarding the interactions of VP3/apoptin of the avian anellovirus with PML NBs is provided. Despite the considerable number of studies that have investigated the functions of the PML NBs in the context of viral infection, gaps in our understanding of the fine interactions between viruses and the very dynamic PML NBs remain. The complexity of the bodies is undoubtedly a great challenge that needs to be further addressed.

Department of Genetics and Microbiology Faculty of Science BIOCEV Charles University Vestec 25250 Czech Republic

Zobrazit více v PubMed

Lamond AI, Earnshaw WC. Structure and function in the nucleus. Science. 1998;280:547–53. doi: 10.1126/science.280.5363.547. PubMed DOI

Mao YS, Zhang B, Spector DL. Biogenesis and function of nuclear bodies. Trends Genet. 2011;27:295–306. doi: 10.1016/j.tig.2011.05.006. PubMed DOI PMC

de Thé G, Riviere M, Bernhard W. Examen au microscope électronique de la tumeur VX2 du lapin domestique dérivée du papillome de Shope. Bull Cancer. 1960;47:570–84. PubMed

Ascoli CA, Maul GG. Identification of a novel nuclear domain. J Cell Biol. 1991;112:785–95. doi: 10.1083/jcb.112.5.785. PubMed DOI PMC

de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991;66:675–84. doi: 10.1016/0092-8674(91)90113-D. PubMed DOI

Daniel MT, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 1993;82:1858–67. doi: 10.1182/blood.V82.6.1858.1858. PubMed DOI

Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 1994;76:333–43. doi: 10.1016/0092-8674(94)90340-9. PubMed DOI

Ishov AM, Maul GG. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol. 1996;134:815–26. doi: 10.1083/jcb.134.4.815. PubMed DOI PMC

Boisvert FM, Hendzel MJ, Bazett-Jones DP. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol. 2000;148. PubMed PMC

Lang M, Jegou T, Chung I, Richter K, Münch S, Udvarhelyi A, et al. Three-dimensional organization of promyelocytic leukemia nuclear bodies. J Cell Sci. 2010;123:392–400. doi: 10.1242/jcs.053496. PubMed DOI

Hofmann TG, Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ Nature Publishing Group. 2003;10:1290–9. doi: 10.1038/sj.cdd.4401313. PubMed DOI

Lallemand-Breitenbach V, de Thé H. PML Nuclear Bodies. Cold Spring Harb Perspect Biol. 2010;2:a000661. doi: 10.1101/cshperspect.a000661. PubMed DOI PMC

Dellaire G, Farrall R, Bickmore WA. The nuclear protein database (NPD): sub-nuclear localisation and functional annotation of the nuclear proteome. Nucleic Acids Res. 2003;31:328–30. doi: 10.1093/nar/gkg018. PubMed DOI PMC

Van Damme E, Laukens K, Dang TH, Van Ostade X. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci. 2010;6:51–67. doi: 10.7150/ijbs.6.51. PubMed DOI PMC

Barroso-Gomila O, Trulsson F, Muratore V, Canosa I, Merino-Cacho L, Cortazar AR, et al. Identification of proximal SUMO-dependent interactors using SUMO-ID. Nat Commun. 2021;12:6671. doi: 10.1038/s41467-021-26807-6. PubMed DOI PMC

Xu P, Roizman B. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments. Proceedings of the National Academy of Sciences. 2017;114:E3823–9. PubMed PMC

Corpet A, Kleijwegt C, Roubille S, Juillard F, Jacquet K, Texier P, et al. PML nuclear bodies and chromatin dynamics: catch me if you can! Nucleic Acids Res. 2020;48:11890–912. doi: 10.1093/nar/gkaa828. PubMed DOI PMC

Fraschilla I, Jeffrey KL. The Speckled protein (SP) family: immunity’s chromatin readers. Trends Immunol. 2020;41:572–85. doi: 10.1016/j.it.2020.04.007. PubMed DOI PMC

Collados RM. The Fate of Speckled Protein 100 (Sp100) During Herpesviruses Infection. Front Cell Infect Microbiol. 2021;10. PubMed PMC

Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100) Clin Exp Immunol. 1987;68:108–16. PubMed PMC

Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 1994;13:1073–83. doi: 10.1002/j.1460-2075.1994.tb06356.x. PubMed DOI PMC

Bloch DB, Nakajima A, Gulick T, Chiche JD, Orth D, de La Monte SM, et al. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol. 2000;20:6138–46. doi: 10.1128/MCB.20.16.6138-6146.2000. PubMed DOI PMC

Salomoni P, The PML-Interacting, Protein DAXX. Histone Loading Gets into the Picture. Front Oncol. 2013;3. PubMed PMC

Mahmud I, Liao D. DAXX in cancer: phenomena, processes, mechanisms and regulation. Nucleic Acids Res. 2019;47:7734–52. doi: 10.1093/nar/gkz634. PubMed DOI PMC

Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999;147:221–34. doi: 10.1083/jcb.147.2.221. PubMed DOI PMC

Li H, Leo C, Zhu J, Wu X, O’Neil J, Park EJ, et al. Sequestration and inhibition of daxx-mediated transcriptional repression by PML. Mol Cell Biol. 2000;20:1784–96. doi: 10.1128/MCB.20.5.1784-1796.2000. PubMed DOI PMC

De La Fuente R, Baumann C, Viveiros MM. Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease. Reproduction. 2011;142:221–34. doi: 10.1530/REP-10-0380. PubMed DOI PMC

Ishov AM, Vladimirova OV, Maul GG, Heterochromatin ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor daxx and SWI/SNF protein ATRX. J Cell Sci. 2004;117:3807–20. doi: 10.1242/jcs.01230. PubMed DOI

Corpet A, Olbrich T, Gwerder M, Fink D, Stucki M. Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle. 2014;13:249–67. doi: 10.4161/cc.26988. PubMed DOI PMC

Stracker TH, Petrini JHJ. The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol. 2011;12:90–103. doi: 10.1038/nrm3047. PubMed DOI PMC

Lombard DB, Guarente L. Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res. 2000;60:2331–4. PubMed

Mirzoeva OK, Petrini JH. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol. 2001;21:281–8. doi: 10.1128/MCB.21.1.281-288.2001. PubMed DOI PMC

Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell death Differ. Nat Publishing Group. 2018;25:104–13. PubMed PMC

Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic ras. Nature. 2000;406:207–10. doi: 10.1038/35018127. PubMed DOI

Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 2000;14:2015–27. doi: 10.1101/gad.14.16.2015. PubMed DOI PMC

Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, et al. The function of PML in p53-dependent apoptosis. Nat Cell Biol. 2000;2:730–6. doi: 10.1038/35036365. PubMed DOI

Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 2000;19. PubMed PMC

Zeng W, Ball AR, Yokomori K. HP1: heterochromatin binding proteins working the genome. Epigenetics. 2010;5:287–92. doi: 10.4161/epi.5.4.11683. PubMed DOI PMC

Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A. 1998;95:7316–21. doi: 10.1073/pnas.95.13.7316. PubMed DOI PMC

Aragón L. The Smc5/6 Complex: New and Old Functions of the enigmatic Long-Distance relative. Annu Rev Genet. 2018;52:89–107. doi: 10.1146/annurev-genet-120417-031353. PubMed DOI

Potts PR, Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol. 2007;14:581–90. doi: 10.1038/nsmb1259. PubMed DOI

Park S-Y, Kim J-S. A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med Nature Publishing Group. 2020;52:204–12. doi: 10.1038/s12276-020-0382-4. PubMed DOI PMC

Wu W-S, Vallian S, Seto E, Yang W-M, Edmondson D, Roth S, et al. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol. 2001;21:2259–68. doi: 10.1128/MCB.21.7.2259-2268.2001. PubMed DOI PMC

Rescher U, Gerke V. S100A10/p11: family, friends and functions. Pflugers Arch. 2008;455:575–82. doi: 10.1007/s00424-007-0313-4. PubMed DOI

Choi J, Chang J-S, Song M-S, Ahn B-Y, Park Y, Lim D-S, et al. Association of hepatitis B virus polymerase with promyelocytic leukemia nuclear bodies mediated by the S100 family protein p11. Biochem Biophys Res Commun. 2003;305:1049–56. doi: 10.1016/S0006-291X(03)00881-7. PubMed DOI

Andrisani OM. Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis. Viruses. 2013;5:858–72. doi: 10.3390/v5030858. PubMed DOI PMC

Kunapuli P, Kasyapa CS, Chin S-F, Caldas C, Cowell JK. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. Exp Cell Res. 2006;312:3739–51. doi: 10.1016/j.yexcr.2006.06.037. PubMed DOI

Chammas P, Mocavini I, Di Croce L. Engaging chromatin: PRC2 structure meets function. Br J Cancer Nature Publishing Group. 2020;122:315–28. PubMed PMC

Villa R, Pasini D, Gutierrez A, Morey L, Occhionorelli M, Viré E, et al. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell. 2007;11:513–25. doi: 10.1016/j.ccr.2007.04.009. PubMed DOI

Liu W, Li Y, Luo B. Current perspective on the regulation of FOXO4 and its role in disease progression. Cell Mol Life Sci. 2020;77:651–63. doi: 10.1007/s00018-019-03297-w. PubMed DOI PMC

Li Y, He M, Gong R, Wang Z, Lu L, Peng S et al. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein. J Virol 96:e00546–22. PubMed PMC

Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene. 2001;20:7223–33. doi: 10.1038/sj.onc.1204765. PubMed DOI

de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991;66:675–84. doi: 10.1016/0092-8674(91)90113-D. PubMed DOI

Goddard AD, Borrow J, Freemont PS, Solomon E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 1991;254:1371–4. doi: 10.1126/science.1720570. PubMed DOI

Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 1992;11:629–42. doi: 10.1002/j.1460-2075.1992.tb05095.x. PubMed DOI PMC

Reddy BA, Etkin LD, Freemont PS. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci. 1992;17:344–5. doi: 10.1016/0968-0004(92)90308-V. PubMed DOI

Borden KL, Boddy MN, Lally J, O’Reilly NJ, Martin S, Howe K, et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 1995;14:1532–41. doi: 10.1002/j.1460-2075.1995.tb07139.x. PubMed DOI PMC

Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20:2140–51. doi: 10.1093/emboj/20.9.2140. PubMed DOI PMC

Boddy MN, Howe K, Etkin LD, Solomon E, Freemont PS. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene. 1996;13:971–82. PubMed

Müller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 1998;17:61–70. doi: 10.1093/emboj/17.1.61. PubMed DOI PMC

Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP. Role of SUMO-1-modified PML in nuclear body formation. Blood. 2000;95:2748–52. doi: 10.1182/blood.V95.9.2748.009k31a_2748_2752. PubMed DOI

Cheng X, Kao H-Y. Post-translational modifications of PML: consequences and implications. Front Oncol. 2012;2:210. PubMed PMC

Patra U, Müller S. A tale of usurpation and subversion: SUMO-Dependent Integrity of promyelocytic Leukemia Nuclear Bodies at the crossroad of infection and immunity. Front Cell Dev Biol. 2021;9:696234. doi: 10.3389/fcell.2021.696234. PubMed DOI PMC

Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, et al. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci. 1999;112:381–93. doi: 10.1242/jcs.112.3.381. PubMed DOI

Shen TH, Lin H-K, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Mol Cell. 2006;24:331–9. doi: 10.1016/j.molcel.2006.09.013. PubMed DOI PMC

Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30:1108–16. doi: 10.1038/onc.2010.462. PubMed DOI PMC

Reuter N, Schilling E-M, Scherer M, Müller R, Stamminger T. The ND10 component promyelocytic leukemia protein Acts as an E3 ligase for SUMOylation of the Major Immediate Early protein IE1 of human cytomegalovirus. J Virol. 2017;91:e02335–16. doi: 10.1128/JVI.02335-16. PubMed DOI PMC

Hsu K-S, Kao H-Y. Regulation and multifaceted function beyond tumor suppression. Cell Biosci. 2018;8:5. doi: 10.1186/s13578-018-0204-8. PubMed DOI PMC

Chang KS, Fan YH, Andreeff M, Liu J, Mu ZM. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood. 1995;85:3646–53. doi: 10.1182/blood.V85.12.3646.bloodjournal85123646. PubMed DOI

Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Differential Roles of PML isoforms. Front Oncol. 2013;3:125. doi: 10.3389/fonc.2013.00125. PubMed DOI PMC

Geoffroy M-C, Chelbi-Alix MK. Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res. 2011;31:145–58. doi: 10.1089/jir.2010.0111. PubMed DOI

Scherer M, Stamminger T. Emerging role of PML Nuclear Bodies in Innate Immune Signaling. J Virol. 2016;90:5850–4. doi: 10.1128/JVI.01979-15. PubMed DOI PMC

Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, et al. The transcriptional coactivator yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell. 2005;18:447–59. doi: 10.1016/j.molcel.2005.04.008. PubMed DOI

Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell. 2008;32:803–14. doi: 10.1016/j.molcel.2008.11.019. PubMed DOI

Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, et al. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell. 2010;18:88–98. doi: 10.1016/j.ccr.2010.06.003. PubMed DOI

Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, et al. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins. J Cell Biol. 2014;204:931–45. doi: 10.1083/jcb.201305148. PubMed DOI PMC

Wang P, Benhenda S, Wu H, Lallemand-Breitenbach V, Zhen T, Jollivet F, et al. RING tetramerization is required for nuclear body biogenesis and PML sumoylation. Nat Commun Nature Publishing Group. 2018;9:1277. doi: 10.1038/s41467-018-03498-0. PubMed DOI PMC

Li Y, Ma X, Chen Z, Wu H, Wang P, Wu W, et al. B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis. Nat Commun Nature Publishing Group. 2019;10:3789. doi: 10.1038/s41467-019-11746-0. PubMed DOI PMC

Wiesmeijer K, Molenaar C, Bekeer IMLA, Tanke HJ, Dirks RW. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J Struct Biol. 2002;140:180–8. doi: 10.1016/S1047-8477(02)00529-4. PubMed DOI

Eskiw CH, Dellaire G, Bazett-Jones DP. Chromatin contributes to Structural Integrity of promyelocytic leukemia bodies through a SUMO-1-independent Mechanism*. J Biol Chem. 2004;279:9577–85. doi: 10.1074/jbc.M312580200. PubMed DOI

Dellaire G, Ching RW, Dehghani H, Ren Y, Bazett-Jones DP. The number of PML nuclear bodies increases in early S phase by a fission mechanism. J Cell Sci. 2006;119:1026–33. doi: 10.1242/jcs.02816. PubMed DOI

Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, et al. Compositional control of phase-separated Cellular Bodies. Cell. 2016;166:651–63. doi: 10.1016/j.cell.2016.06.010. PubMed DOI PMC

Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP. PML bodies: a meeting place for genomic loci? J Cell Sci. 2005;118:847–54. doi: 10.1242/jcs.01700. PubMed DOI

El Bougrini J, Dianoux L, Chelbi-Alix MK. PML positively regulates interferon gamma signaling. Biochimie. 2011;93:389–98. doi: 10.1016/j.biochi.2010.11.005. PubMed DOI

Ulbricht T, Alzrigat M, Horch A, Reuter N, von Mikecz A, Steimle V, et al. PML promotes MHC class II gene expression by stabilizing the class II transactivator. J Cell Biol. 2012;199:49–63. doi: 10.1083/jcb.201112015. PubMed DOI PMC

Chen Y, Wright J, Meng X, Leppard KN. Promyelocytic leukemia protein isoform II promotes transcription factor recruitment to activate Interferon Beta and Interferon-Responsive Gene expression. Mol Cell Biol. 2015;35:1660–72. doi: 10.1128/MCB.01478-14. PubMed DOI PMC

Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays. 2004;26:963–77. doi: 10.1002/bies.20089. PubMed DOI

Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol Nature Publishing Group. 2007;8:1006–16. doi: 10.1038/nrm2277. PubMed DOI

Chang HR, Munkhjargal A, Kim M-J, Park SY, Jung E, Ryu J-H, et al. The functional roles of PML nuclear bodies in genome maintenance. Mutat Res. 2018;809:99–107. doi: 10.1016/j.mrfmmm.2017.05.002. PubMed DOI

Chung I, Osterwald S, Deeg KI, Rippe K. PML body meets telomere. Nucleus. 2012;3:263–75. doi: 10.4161/nucl.20326. PubMed DOI PMC

Chelbi-Alix MK, de Thé H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene. 1999;18:935–41. doi: 10.1038/sj.onc.1202366. PubMed DOI

Müller S, Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol. 1999;73:5137–43. doi: 10.1128/JVI.73.6.5137-5143.1999. PubMed DOI PMC

Boutell C, Cuchet-Lourenço D, Vanni E, Orr A, Glass M, McFarlane S, et al. A viral ubiquitin ligase has substrate preferential SUMO targeted Ubiquitin Ligase activity that counteracts intrinsic Antiviral Defence. PLoS Pathog. 2011;7:e1002245. doi: 10.1371/journal.ppat.1002245. PubMed DOI PMC

Tavalai N, Stamminger T. Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res. 2011;157:128–33. doi: 10.1016/j.virusres.2010.10.002. PubMed DOI

Tsai K, Messick TE, Lieberman PM. Disruption of host antiviral resistances by Gammaherpesvirus Tegument Proteins with homology to the FGARAT purine biosynthesis enzyme. Curr Opin Virol. 2015;14:30–40. doi: 10.1016/j.coviro.2015.07.008. PubMed DOI PMC

Full F, Hahn AS, Großkopf AK, Ensser A. Gammaherpesviral Tegument Proteins, PML-Nuclear Bodies and the Ubiquitin-Proteasome System. Viruses. 2017;9. PubMed PMC

Scherer M, Schilling E-M, Stamminger T. The human CMV IE1 protein: an offender of PML nuclear bodies. Adv Anat Embryol Cell Biol. 2017;223:77–94. doi: 10.1007/978-3-319-53168-7_4. PubMed DOI

Jan Fada B, Reward E, Gu H. The role of ND10 Nuclear Bodies in Herpesvirus infection: a frenemy for the Virus? Viruses. 2021;13:239. doi: 10.3390/v13020239. PubMed DOI PMC

Mathavarajah S, Vergunst KL, Habib EB, Williams SK, He R, Maliougina M et al. PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates. Nucleic Acids Res. 2023;gkad152. PubMed PMC

Gamdzyk M, Doycheva DM, Araujo C, Ocak U, Luo Y, Tang J, et al. cGAS/STING pathway activation contributes to delayed neurodegeneration in neonatal hypoxia-ischemia rat model: possible involvement of LINE-1. Molecular neurobiology. NIH Public Access. 2020;57:2600. PubMed PMC

Gallardo J, Pérez-Illana M, Martín-González N. San Martín C. Adenovirus structure: what is New? Int J Mol Sci. 2021;22:5240. doi: 10.3390/ijms22105240. PubMed DOI PMC

Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, Akusjärvi G, et al. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol. 1995;131:45–56. doi: 10.1083/jcb.131.1.45. PubMed DOI PMC

Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, et al. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 1996;10:196–207. doi: 10.1101/gad.10.2.196. PubMed DOI

Hoppe A, Beech SJ, Dimmock J, Leppard KN. Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol. 2006;80:3042–9. doi: 10.1128/JVI.80.6.3042-3049.2006. PubMed DOI PMC

Ou HD, Kwiatkowski W, Deerinck TJ, Noske A, Blain KY, Land HS, et al. A structural basis for the Assembly and Functions of a viral polymer that inactivates multiple tumor suppressors. Cell Elsevier. 2012;151:304–19. doi: 10.1016/j.cell.2012.08.035. PubMed DOI PMC

Stracker TH, Carson CT, Weitzman MD. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 2002;418:348–52. doi: 10.1038/nature00863. PubMed DOI

Weiden MD, Ginsberg HS. Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc Natl Acad Sci U S A. 1994;91:153–7. doi: 10.1073/pnas.91.1.153. PubMed DOI PMC

Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J Virol. 2001;75:699–709. doi: 10.1128/JVI.75.2.699-709.2001. PubMed DOI PMC

Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, et al. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 2001;15:3104–17. doi: 10.1101/gad.926401. PubMed DOI PMC

Liu Y, Shevchenko A, Shevchenko A, Berk AJ. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J Virol. 2005;79:14004–16. doi: 10.1128/JVI.79.22.14004-14016.2005. PubMed DOI PMC

Sohn S-Y, Hearing P. Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism. J Virol. 2012;86:9656–65. doi: 10.1128/JVI.01273-12. PubMed DOI PMC

Sohn S-Y, Hearing P. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation. Proc Natl Acad Sci U S A. 2016;113:6725–30. doi: 10.1073/pnas.1603872113. PubMed DOI PMC

Higginbotham JM, O’Shea CC. Adenovirus E4-ORF3 targets PIAS3 and together with E1B-55K remodels SUMO interactions in the Nucleus and at Virus Genome Replication Domains. J Virol. 2015;89:10260–72. doi: 10.1128/JVI.01091-15. PubMed DOI PMC

Ullman AJ, Hearing P. Cellular proteins PML and daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol. 2008;82:7325–35. doi: 10.1128/JVI.00723-08. PubMed DOI PMC

Ullman AJ, Reich NC, Hearing P. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol. 2007;81:4744–52. doi: 10.1128/JVI.02385-06. PubMed DOI PMC

Schreiner S, Wimmer P, Sirma H, Everett RD, Blanchette P, Groitl P, et al. Proteasome-dependent degradation of daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol. 2010;84:7029–38. doi: 10.1128/JVI.00074-10. PubMed DOI PMC

Müncheberg S, Hay RT, Ip WH, Meyer T, Weiß C, Brenke J, et al. E1B-55K-Mediated regulation of RNF4 SUMO-Targeted ubiquitin ligase promotes human adenovirus gene expression. J Virol. 2018;92:e00164–18. doi: 10.1128/JVI.00164-18. PubMed DOI PMC

Schreiner S, Bürck C, Glass M, Groitl P, Wimmer P, Kinkley S, et al. Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res. 2013;41:3532–50. doi: 10.1093/nar/gkt064. PubMed DOI PMC

Schreiner S, Martinez R, Groitl P, Rayne F, Vaillant R, Wimmer P, et al. Transcriptional activation of the Adenoviral genome is mediated by capsid protein VI. PLoS Pathog. 2012;8:e1002549. doi: 10.1371/journal.ppat.1002549. PubMed DOI PMC

Tatsis N, Ertl HCJ. Adenoviruses as vaccine vectors. Mol Ther. 2004;10:616–29. doi: 10.1016/j.ymthe.2004.07.013. PubMed DOI PMC

Berscheminski J, Groitl P, Dobner T, Wimmer P, Schreiner S. The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription. J Virol. 2013;87:965–77. doi: 10.1128/JVI.02023-12. PubMed DOI PMC

Berscheminski J, Wimmer P, Brun J, Ip WH, Groitl P, Horlacher T, et al. Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol. 2014;88:6076–92. doi: 10.1128/JVI.00469-14. PubMed DOI PMC

Stubbe M, Mai J, Paulus C, Stubbe HC, Berscheminski J, Karimi M, et al. Viral DNA binding protein SUMOylation promotes PML nuclear body localization next to viral replication Centers. mBio. 2020;11:e00049–20. doi: 10.1128/mBio.00049-20. PubMed DOI PMC

Komatsu T, Nagata K, Wodrich H. An adenovirus DNA replication factor, but not incoming genome complexes, targets PML Nuclear Bodies. J Virol. 2016;90:1657–67. doi: 10.1128/JVI.02545-15. PubMed DOI PMC

McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20:95–108. doi: 10.1038/s41579-021-00617-5. PubMed DOI

Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314:111–4. doi: 10.1038/314111a0. PubMed DOI

Pešut E, Đukić A, Lulić L, Skelin J, Šimić I, Milutin Gašperov N, et al. Human Papillomaviruses-Associated Cancers: an update of current knowledge. Viruses. 2021;13:2234. doi: 10.3390/v13112234. PubMed DOI PMC

Stoler MH, Whitbeck A, Wolinsky SM, Broker TR, Chow LT, Howett MK, et al. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol. 1990;64:3310–8. doi: 10.1128/jvi.64.7.3310-3318.1990. PubMed DOI PMC

Moody C. Mechanisms by which HPV induces a replication competent environment in differentiating keratinocytes. Viruses. 2017;9:261. doi: 10.3390/v9090261. PubMed DOI PMC

McBride AA. Mechanisms and strategies of papillomavirus replication. Biol Chem. 2017;398:919–27. doi: 10.1515/hsz-2017-0113. PubMed DOI

Beyer-Finkler E, Stoler MarkH, Girardi F, Pfister H. Cell differentiation-related gene expression of human papillomavirus 33. Med Microbiol Immunol. 1990;179. PubMed

Bedell MA, Hudson JB, Golub TR, Turyk ME, Hosken M, Wilbanks GD, et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol. 1991;65:2254–60. doi: 10.1128/jvi.65.5.2254-2260.1991. PubMed DOI PMC

Day PM, Roden RB, Lowy DR, Schiller JT. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol. 1998;72:142–50. doi: 10.1128/JVI.72.1.142-150.1998. PubMed DOI PMC

Wang JW, Roden RBS. L2, the minor capsid protein of papillomavirus. Virology. 2013;445:175–86. doi: 10.1016/j.virol.2013.04.017. PubMed DOI PMC

DiGiuseppe S, Bienkowska-Haba M, Guion LGM, Keiffer TR, Sapp M. Human papillomavirus major capsid protein L1 remains Associated with the incoming viral genome throughout the entry process. J Virol. 2017;91:e00537–17. doi: 10.1128/JVI.00537-17. PubMed DOI PMC

DiGiuseppe S, Bienkowska-Haba M, Hilbig L, Sapp M. The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-golgi network. Virology. 2014;458–459:93–105. doi: 10.1016/j.virol.2014.04.024. PubMed DOI PMC

Popa A, Zhang W, Harrison MS, Goodner K, Kazakov T, Goodwin EC, et al. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PLoS Pathog. 2015;11:e1004699. doi: 10.1371/journal.ppat.1004699. PubMed DOI PMC

Aydin I, Weber S, Snijder B, Samperio Ventayol P, Kühbacher A, Becker M, et al. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog. 2014;10:e1004162. doi: 10.1371/journal.ppat.1004162. PubMed DOI PMC

Day PM, Weisberg AS, Thompson CD, Hughes MM, Pang YY, Lowy DR, et al. Human papillomavirus 16 Capsids Mediate Nuclear entry during infection. J Virol. 2019;93:e00454–19. doi: 10.1128/JVI.00454-19. PubMed DOI PMC

Florin L, Schäfer F, Sotlar K, Streeck RE, Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology. 2002;295:97–107. doi: 10.1006/viro.2002.1360. PubMed DOI

Becker KA, Florin L, Sapp C, Sapp M. Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology. 2003;314:161–7. doi: 10.1016/S0042-6822(03)00447-1. PubMed DOI

Tang SY, Li L, Liu Y, Liu AY, Yu MJ, Zhang Y, et al. [Interaction of DAXX and human papillomavirus type 16 E2 protein] Mol Biol (Mosk) 2014;48:682–6. doi: 10.1134/S0026893314040165. PubMed DOI

Roberts S, Hillman ML, Knight GL, Gallimore PH. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts. J Virol. 2003;77:673–84. doi: 10.1128/JVI.77.1.673-684.2003. PubMed DOI PMC

Day PM, Baker CC, Lowy DR, Schiller JT. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci USA. 2004;101:14252–7. doi: 10.1073/pnas.0404229101. PubMed DOI PMC

Bienkowska-Haba M, Luszczek W, Keiffer TR, Guion LGM, DiGiuseppe S, Scott RS, et al. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes. Cell Microbiol. 2017;19:e12708. doi: 10.1111/cmi.12708. PubMed DOI PMC

Bund T, Spoden GA, Koynov K, Hellmann N, Boukhallouk F, Arnold P, et al. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16: SIM-based SUMO interaction of HPV16 L2. Cell Microbiol. 2014;16:1179–200. doi: 10.1111/cmi.12271. PubMed DOI

Guion L, Bienkowska-Haba M, DiGiuseppe S, Florin L, Sapp M. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery. PLoS Pathog. 2019;15:e1007590. doi: 10.1371/journal.ppat.1007590. PubMed DOI PMC

Kivipõld P, Võsa L, Ustav M, Kurg R. DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells. Virol J. 2015;12:104. doi: 10.1186/s12985-015-0335-z. PubMed DOI PMC

Schweiger L, Lelieveld-Fast LA, Mikuličić S, Strunk J, Freitag K, Tenzer S, et al. HPV16 induces formation of Virus-p62-PML hybrid bodies to enable infection. Viruses. 2022;14:1478. doi: 10.3390/v14071478. PubMed DOI PMC

Stepp WH, Meyers JM, McBride AA. Sp100 provides intrinsic immunity against human papillomavirus infection. mBio. 2013;4:e00845–13. doi: 10.1128/mBio.00845-13. PubMed DOI PMC

Stepp WH, Stamos JD, Khurana S, Warburton A, McBride AA. Sp100 colocalizes with HPV replication foci and restricts the productive stage of the infectious cycle. PLoS Pathog. 2017;13:e1006660. doi: 10.1371/journal.ppat.1006660. PubMed DOI PMC

Cook L, Polyomaviruses. Microbiol Spectr. 2016;4. PubMed

Ehlers B, Moens U. Genome analysis of non-human primate polyomaviruses. Infect Genet Evol. 2014;26:283–94. doi: 10.1016/j.meegid.2014.05.030. PubMed DOI

Prado JCM, Monezi TA, Amorim AT, Lino V, Paladino A, Boccardo E. Human polyomaviruses and cancer: an overview. Clin (Sao Paulo) 2018;73:e558s. doi: 10.6061/clinics/2018/e558s. PubMed DOI PMC

Gerits N, Moens U. Agnoprotein of mammalian polyomaviruses. Virology. 2012;432:316–26. doi: 10.1016/j.virol.2012.05.024. PubMed DOI PMC

Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1:1253–7. doi: 10.1016/S0140-6736(71)91776-4. PubMed DOI

Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;1:1257–60. doi: 10.1016/S0140-6736(71)91777-6. PubMed DOI

Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a Polyomavirus in Human Merkel Cell Carcinoma. Science. 2008;319:1096–100. doi: 10.1126/science.1152586. PubMed DOI PMC

Horníková L, Bruštíková K, Forstová J. Microtubules in Polyomavirus infection. Viruses. 2020;12:121. doi: 10.3390/v12010121. PubMed DOI PMC

Jul-Larsen A, Visted T, Karlsen BO, Rinaldo CH, Bjerkvig R, Lønning PE, et al. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Exp Cell Res. 2004;298:58–73. doi: 10.1016/j.yexcr.2004.03.045. PubMed DOI

Jiang WQ, Szekely L, Klein G, Ringertz N. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. Exp Cell Res. 1996;229:289–300. doi: 10.1006/excr.1996.0374. PubMed DOI

Tang Q, Bell P, Tegtmeyer P, Maul GG. Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J Virol. 2000;74:9694–700. doi: 10.1128/JVI.74.20.9694-9700.2000. PubMed DOI PMC

Lanson NA, Egeland DB, Royals BA, Claycomb WC. The MRE11-NBS1-RAD50 pathway is perturbed in SV40 large T antigen-immortalized AT-1, AT-2 and HL-1 cardiomyocytes. Nucleic Acids Res. 2000;28:2882–92. doi: 10.1093/nar/28.15.2882. PubMed DOI PMC

Digweed M, Demuth I, Rothe S, Scholz R, Jordan A, Grötzinger C, et al. SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11. Oncogene. 2002;21:4873–8. doi: 10.1038/sj.onc.1205616. PubMed DOI

Jiang M, Entezami P, Gamez M, Stamminger T, Imperiale MJ. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. mBio. 2011;2:e00281–00210. doi: 10.1128/mBio.00281-11. PubMed DOI PMC

Erickson KD, Bouchet-Marquis C, Heiser K, Szomolanyi-Tsuda E, Mishra R, Lamothe B, et al. Virion assembly factories in the nucleus of polyomavirus-infected cells. PLoS Pathog. 2012;8:e1002630. doi: 10.1371/journal.ppat.1002630. PubMed DOI PMC

Neumann F, Czech-Sioli M, Dobner T, Grundhoff A, Schreiner S, Fischer N. Replication of Merkel cell polyomavirus induces reorganization of promyelocytic leukemia nuclear bodies. J Gen Virol. 2016;97:2926–38. doi: 10.1099/jgv.0.000593. PubMed DOI

Shishido-Hara Y, Yazawa T, Nagane M, Higuchi K, Abe-Suzuki S, Kurata M, et al. JC virus inclusions in progressive multifocal leukoencephalopathy: scaffolding promyelocytic leukemia nuclear bodies grow with cell cycle transition through an S-to-G2-like state in enlarging oligodendrocyte nuclei. J Neuropathol Exp Neurol. 2014;73:442–53. doi: 10.1097/NEN.0000000000000066. PubMed DOI PMC

Shishido-Hara Y, Higuchi K, Ohara S, Duyckaerts C, Hauw J-J, Uchihara T. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2008;67:299–308. doi: 10.1097/NEN.0b013e31816a1dd3. PubMed DOI

Shishido-Hara Y, Ichinose S, Higuchi K, Hara Y, Yasui K. Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol. 2004;78:9890–903. doi: 10.1128/JVI.78.18.9890-9903.2004. PubMed DOI PMC

Shishido-Hara Y, Ichinose S, Uchihara T. JC virus intranuclear inclusions associated with PML-NBs: analysis by electron microscopy and structured illumination microscopy. Am J Pathol. 2012;180:1095–106. doi: 10.1016/j.ajpath.2011.11.036. PubMed DOI

Assetta B, De Cecco M, O’Hara B, Atwood WJ. JC Polyomavirus infection of primary human renal epithelial cells is controlled by a type I IFN-Induced response. mBio. 2016;7:e00903–16. doi: 10.1128/mBio.00903-16. PubMed DOI PMC

Datta S, Chatterjee S, Veer V, Chakravarty R. Molecular biology of the hepatitis B virus for clinicians. J Clin Exp Hepatol. 2012;2:353–65. doi: 10.1016/j.jceh.2012.10.003. PubMed DOI PMC

Hepatitis B, [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.

Dill JA, Camus AC, Leary JH, Di Giallonardo F, Holmes EC, Ng TFF. Distinct viral lineages from Fish and Amphibians reveal the Complex Evolutionary History of Hepadnaviruses. J Virol. 2016;90:7920–33. doi: 10.1128/JVI.00832-16. PubMed DOI PMC

Yoon GS, Yu E. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis. J Korean Med Sci. 2001;16:433–8. doi: 10.3346/jkms.2001.16.4.433. PubMed DOI PMC

Chung Y-L, Tsai T-Y. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy. Mol Cancer Res. 2009;7:1672–85. doi: 10.1158/1541-7786.MCR-09-0112. PubMed DOI

Li L, Li Y, Xiong Z, Shu W, Yang Y, Guo Z, et al. FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α. Antiviral Res. 2019;170:104568. doi: 10.1016/j.antiviral.2019.104568. PubMed DOI

Li Y, He M, Gong R, Wang Z, Lu L, Peng S, et al. Forkhead O transcription factor 4 restricts HBV covalently closed circular DNA transcription and HBV replication through genetic downregulation of hepatocyte nuclear factor 4 alpha and epigenetic suppression of covalently closed circular DNA via interacting with promyelocytic leukemia protein. J Virol. 2022;96:e0054622. doi: 10.1128/jvi.00546-22. PubMed DOI PMC

Studach L, Wang W-H, Weber G, Tang J, Hullinger RL, Malbrue R, et al. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J Biol Chem. 2010;285:30282–93. doi: 10.1074/jbc.M109.093963. PubMed DOI PMC

Zhang H, Diab A, Fan H, Mani SKK, Hullinger R, Merle P, et al. PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. Cancer Res. 2015;75:2363–74. doi: 10.1158/0008-5472.CAN-14-2928. PubMed DOI PMC

Wang W-H, Studach LL, Andrisani OM. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology. 2011;53:1137–47. doi: 10.1002/hep.24163. PubMed DOI PMC

Yoon J-H, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K, et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun. 2013;4:2939. doi: 10.1038/ncomms3939. PubMed DOI PMC

Sengupta I, Das D, Singh SP, Chakravarty R, Das C. Host transcription factor speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence. J Biol Chem. 2017;292:20379–93. doi: 10.1074/jbc.M117.796839. PubMed DOI PMC

Kegel A, Sjögren C. The Smc5/6 complex: more than repair? Cold Spring Harb Symp Quant Biol. 2010;75:179–87. doi: 10.1101/sqb.2010.75.047. PubMed DOI

Decorsière A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, et al. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature. 2016;531:386–9. doi: 10.1038/nature17170. PubMed DOI

Murphy CM, Xu Y, Li F, Nio K, Reszka-Blanco N, Li X, et al. Hepatitis B Virus X protein promotes degradation of SMC5/6 to enhance HBV replication. Cell Rep. 2016;16:2846–54. doi: 10.1016/j.celrep.2016.08.026. PubMed DOI PMC

Kanno T, Berta DG, Sjögren C. The Smc5/6 complex is an ATP-Dependent intermolecular DNA linker. Cell Rep. 2015;12:1471–82. doi: 10.1016/j.celrep.2015.07.048. PubMed DOI

Angers S, Li T, Yi X, MacCoss MJ, Moon RT, Zheng N. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature. 2006;443:590–3. doi: 10.1038/nature05175. PubMed DOI

Minor MM, Hollinger FB, McNees AL, Jung SY, Jain A, Hyser JM, et al. Hepatitis B Virus HBx protein mediates the degradation of host restriction factors through the Cullin 4 DDB1 E3 ubiquitin ligase complex. Cells. 2020;9:834. doi: 10.3390/cells9040834. PubMed DOI PMC

Abdul F, Filleton F, Gerossier L, Paturel A, Hall J, Strubin M, et al. Smc5/6 antagonism by HBx is an evolutionarily conserved function of Hepatitis B Virus infection in mammals. J Virol. 2018;92:e00769–18. doi: 10.1128/JVI.00769-18. PubMed DOI PMC

van Breugel PC, Robert EI, Mueller H, Decorsière A, Zoulim F, Hantz O, et al. Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates. Hepatology. 2012;56:2116–24. doi: 10.1002/hep.25928. PubMed DOI

Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, et al. The Smc5/6 Complex restricts HBV when localized to ND10 without inducing an Innate Immune Response and is counteracted by the HBV X protein shortly after infection. PLOS ONE Public Library of Science. 2017;12:e0169648. doi: 10.1371/journal.pone.0169648. PubMed DOI PMC

Abdul F, Diman A, Baechler B, Ramakrishnan D, Kornyeyev D, Beran RK, et al. Smc5/6 silences episomal transcription by a three-step function. Nat Struct Mol Biol. 2022;29:922–31. doi: 10.1038/s41594-022-00829-0. PubMed DOI

Xu W, Ma C, Zhang Q, Zhao R, Hu D, Zhang X, et al. PJA1 coordinates with the SMC5/6 Complex to restrict DNA viruses and episomal genes in an Interferon-Independent Manner. J Virol. 2018;92:e00825–18. doi: 10.1128/JVI.00825-18. PubMed DOI PMC

Van Damme E, Vanhove J, Severyn B, Verschueren L, Pauwels F. The Hepatitis B Virus Interactome: a comprehensive overview. Front Microbiol. 2021;12:724877. doi: 10.3389/fmicb.2021.724877. PubMed DOI PMC

Kakkola L, Tommiska J, Boele LCL, Miettinen S, Blom T, Kekarainen T, et al. Construction and biological activity of a full-length molecular clone of human Torque teno virus (TTV) genotype 6. FEBS J. 2007;274:4719–30. doi: 10.1111/j.1742-4658.2007.06020.x. PubMed DOI

Wawrzyniak P, Płucienniczak G, Bartosik D. The different faces of Rolling-Circle replication and its multifunctional initiator proteins. Front Microbiol. 2017;8:2353. doi: 10.3389/fmicb.2017.02353. PubMed DOI PMC

Kaczorowska J, van der Hoek L. Human anelloviruses: diverse, omnipresent and commensal members of the virome. FEMS Microbiol Rev. 2020;44:305–13. doi: 10.1093/femsre/fuaa007. PubMed DOI PMC

Freer G, Maggi F, Pifferi M, Di Cicco ME, Peroni DG, Pistello M. The Virome and its major component, Anellovirus, a Convoluted System Molding Human Immune Defenses and possibly affecting the development of Asthma and Respiratory Diseases in Childhood. Front Microbiol. 2018;9:686. doi: 10.3389/fmicb.2018.00686. PubMed DOI PMC

Bal A, Destras G, Sabatier M, Pichon M, Regue H, Oriol G, et al. Metagenomic analysis reveals high abundance of Torque Teno Mini Virus in the respiratory tract of children with Acute Respiratory illness. Viruses. 2022;14:955. doi: 10.3390/v14050955. PubMed DOI PMC

Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997;241:92–7. doi: 10.1006/bbrc.1997.7765. PubMed DOI

Li Y, Fang L, Cui S, Fu J, Li X, Zhang H, et al. Genomic characterization of recent chicken Anemia virus isolates in China. Front Microbiol. 2017;8:401. PubMed PMC

Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A. 1997;94:5843–7. doi: 10.1073/pnas.94.11.5843. PubMed DOI PMC

Danen-Van Oorschot AAAM, Zhang Y-H, Leliveld SR, Rohn JL, Seelen MCMJ, Bolk MW, et al. Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem. 2003;278:27729–36. doi: 10.1074/jbc.M303114200. PubMed DOI

Oro C, Jans DA. The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus. Curr Drug Targets. 2004;5:179–90. doi: 10.2174/1389450043490631. PubMed DOI

Natesan S, Kataria JM, Dhama K, Bhardwaj N, Sylvester A. Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in rous sarcoma virus-induced tumours in chicken. J Gen Virol. 2006;87:2933–40. doi: 10.1099/vir.0.82085-0. PubMed DOI

Poon IKH, Oro C, Dias MM, Zhang J-P, Jans DA. A tumor cell-specific nuclear targeting signal within chicken anemia virus VP3/apoptin. J Virol. 2005;79:1339–41. doi: 10.1128/JVI.79.2.1339-1341.2005. PubMed DOI PMC

Rohn JL, Zhang Y-H, Aalbers RIJM, Otto N, Den Hertog J, Henriquez NV, et al. A tumor-specific kinase activity regulates the viral death protein apoptin. J Biol Chem. 2002;277:50820–7. doi: 10.1074/jbc.M208557200. PubMed DOI

Heilman DW, Teodoro JG, Green MR. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol. 2006;80:7535–45. doi: 10.1128/JVI.02741-05. PubMed DOI PMC

Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff K, Fischer U. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene. 2007;26:1557–66. doi: 10.1038/sj.onc.1209923. PubMed DOI

Cobb AM, De Silva SA, Hayward R, Sek K, Ulferts S, Grosse R, et al. Filamentous nuclear actin regulation of PML NBs during the DNA damage response is deregulated by prelamin A. Cell Death Dis. 2022;13:1042. doi: 10.1038/s41419-022-05491-4. PubMed DOI PMC

Mouse polyomavirus infection induces lamin reorganisation